What's behind Scripps's latest 3.6% stock surge?

Traders Union
All News
Financial News
E. w. scripps co surges 3.63% today

Highlights

Scripps shows short-term outperformance but remains below key longer-term averages, indicating a prevailing bearish trend.
Momentum indicators, including MACD and RSI, signal sustained selling pressure and lack of bullish conviction.
The forecast range for the next five sessions is $2.82 to $3.17, with over 80% probability favoring a downside move below $2.92 support.

Anton Kharitonov, expert at Traders Union, sees the price action in E. W. Scripps Co Class A as a technical bounce with little fundamental support. The lack of relevant news weakens sentiment and raises doubts about the sustainability of the move. Momentum indicators point to prevailing bearish pressure, reinforced by the stock's position below key moving averages. The risk of a false breakout remains high, especially with sellers dominating longer-term trends. "I remain skeptical about upside prospects given the absence of catalysts and continued weak momentum," Kharitonov says.

Viktoras Karapetjanc, expert at Traders Union, emphasizes the constructive potential in Scripps’ recent rebound and sees near-term opportunity. Despite missing fresh headlines, he believes the current momentum above the 20-day average reveals underlying demand. The technical setup shows room for price expansion if $3.04 breaks decisively, with the bullish structure offering setups for nimble traders. "Further growth is likely if buying pressure persists — the market offers a window for optimistic participants," Karapetjanc notes.

Jainam Mehta, market strategist, notes the sideways drift anchored above $2.92 as a classic volatility contraction. He observes that momentum signals remain negative, but price holding above short-term support invites tactical setups. Mehta suggests watching for either a breakdown or a contrarian breakout above resistance. "A move beyond $3.04 or a failure at $2.92 can provide tradable signals for both bulls and bears," says Mehta.

Bearish technical backdrop despite intraday gains as momentum lags

Scripps is trading above the 20-day moving average (MA-20) at $2.92, but remains below both the 50-day (MA-50) at $3.47 and 200-day (MA-200) at $3.56 averages. This setup reflects short-term upside against longer-term bearish pressure, with the Ichimoku Kijun at $3.09 acting as resistance and a bearish longer-term trend signaled by MA alignment. The nearest support is found at $2.92, with resistance at the session high of $3.04. Momentum readings show a weak backdrop: Moving Average Convergence Divergence (MACD) points to strong selling pressure and the Average Directional Index (ADX) registers neutral trend strength. The Relative Strength Index (RSI) is subdued and signals a sell bias, while Stochastic RSI echoes a strong sell. Commodity Channel Index (CCI) and Awesome Oscillator (AO) read neutral. Bull/Bear Power (BBP) is marginally positive at 0.14, indicating buyers are narrowly in control on an intraday basis, and no overbought/oversold condition is present. The stock climbed to $3, an increase of $0.105 or 3.63%, after opening with a downside gap of about $0.02 (0.69%). Price is currently near the session high, with daily volatility amplitude at 5.92%. Despite firm intraday price action, momentum and oscillators remain broadly negative, highlighting a potential divergence.

Earlier, analysts noted that Scripps faced persistent downside risk, with technical signals reflecting ongoing seller control and a lack of clear bullish momentum. While the current article highlights a short-term rebound, the broader setup still favors cautious positioning, with traders advised to closely monitor price action at the $3.04 resistance as a possible pivot for the next move.

Source of Data: SSP Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.